Stay updated on Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page displays the completed NCT02500121 study record for a phase II trial of maintenance pembrolizumab versus placebo in metastatic urothelial cancer, including study details and posted outcomes.SummaryDifference69%

- Check21 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible on a 403 error page.SummaryDifference0.2%

- Check28 days agoChange DetectedA banner announces an NIH website terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe footer now identifies the site revision as v3.7.2 instead of v3.7.1. The study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study details and navigation with an access-denied message. This indicates the site is blocking access to the record.SummaryDifference19%

Stay in the know with updates to Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page.